Related Experiment Video
Updated: May 31, 2025
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
Effects of MeCP2 on chronic seizures and cognitive function in mice with temporal lobe epilepsy
Yu Chen1, Shu-Nan Yang1, Guan-Ling Fu1
1Institute of Neurobiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 West Yanta Road, Xi'an City 710061, China; Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 West Yanta Road, Xi'an City 710061, China; Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, 76 West Yanta Road, Xi'an City 710061, China.
Abstract:
Mutations in methyl CpG binding protein 2 (MeCP2) are linked to Rett syndrome, in which epilepsy is one of the most well-described disorders. However, little is known about the specific role of MeCP2 during epileptogenesis. Our previous study has demonstrated that MeCP2 has a unique control on the development of mossy fiber sprouting (MFS) in the epileptic hippocampus. This study aimed to (1) examine whether MeCP2 affects spontaneous recurrent seizures (SRSs) and cognitive deficits in mice with pilocarpine-induced epilepsy, and (2) profile MeCP2's downstream molecular events. In the dentate gyrus (DG), we found that over-expression or suppression of MeCP2 significantly reduced or increased the frequency, duration, and number of stage 5 seizures of SRSs during the chronic stage after the SE. Over-expression of MeCP2 improved cognitive deficits in TLE mice, while exacerbated cognitive performances were observed following MeCP2 knockdown. Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA-sequence analyses revealed that MeCP2-targeted genes have far‑reaching impacts on the pathophysiological events during epileptogenesis, including neuron differentiation, neurogenesis, axon guidance, and so on.
Insights
Methyl CpG binding protein 2 (MeCP2) influences epilepsy and cognitive function in mouse models. Modulating MeCP2 levels impacts seizure activity and learning, revealing its role in epileptogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Mutations in methyl CpG binding protein 2 (MeCP2) are associated with Rett syndrome and its prominent neurological disorder, epilepsy.
- The precise role of MeCP2 in the development of epilepsy (epileptogenesis) remains largely uncharacterized.
- Previous research indicated MeCP2's involvement in mossy fiber sprouting (MFS) within the epileptic hippocampus.
Purpose of the Study:
- To investigate the effect of MeCP2 on spontaneous recurrent seizures (SRSs) and cognitive impairments in a mouse model of pilocarpine-induced epilepsy.
- To identify and analyze the downstream molecular targets regulated by MeCP2 during epileptogenesis.
Main Methods:
- Pilocarpine-induced epilepsy model in mice.
- Manipulation of MeCP2 expression (over-expression and knockdown) in the dentate gyrus (DG).
- Assessment of seizure frequency, duration, and severity.
- Evaluation of cognitive performance.
- Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) analyses.
Main Results:
- Altering MeCP2 levels in the DG significantly modulated the frequency, duration, and severity of SRSs in the chronic epilepsy stage.
- Over-expression of MeCP2 ameliorated cognitive deficits, whereas MeCP2 knockdown exacerbated them in temporal lobe epilepsy (TLE) mice.
- ChIP-seq and RNA-seq identified numerous MeCP2-targeted genes involved in crucial pathophysiological processes like neuron differentiation, neurogenesis, and axon guidance.
Conclusions:
- MeCP2 plays a critical role in regulating seizure activity and cognitive function in the context of epilepsy.
- MeCP2 exerts its influence through a broad network of downstream genes affecting neuronal development and function.
- Targeting MeCP2 pathways may offer therapeutic strategies for epilepsy and associated cognitive deficits.
